8:22 AM
Leo Group India
| ||
| New drug policy will hurt investment in pharma sector: Industry NDTV New Delhi: Prices of various leading drug brands will come down by up to 80 per cent thanks to the newly-approved National Pharmaceutical Pricing Policy but at the same time it will hurt investment sentiments in the country's pharmaceutical sector, ... See all stories on this topic » | ||
| China Nuokang Bio-Pharmaceutical Inc. Reports Third Quarter 2012 Financial ... NASDAQ BEIJING, Nov. 25, 2012 (GLOBE NEWSWIRE) -- China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) ("Nuokang" or the "Company"), a leading China-based biopharmaceutical company focused on the research, development, manufacture, marketing and ... See all stories on this topic » | ||
| GoM has resolved all issues on drug pricing policy: Pawar Hindu Business Line The Group of Ministers on pharmaceutical pricing policy has resolved all issues, claimed its Chairman Sharad Pawar here on Wednesday. Talking to reporters after a meeting of the GoM, Pawar said the policy would now go the Cabinet for its final approval. See all stories on this topic » | ||
| مندوب تحصيل -Collection Representative Emirates 24/7 Since establishment in 1996 as an authorized distributor for Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO), ARAC powerfully penetrated the Kingdom's market of pharmaceuticals and relevant healthcare products distribution. See all stories on this topic » | ||
| Elder Pharma set to enter regulated markets of EU Hindu Business Line Elder Pharmaceuticals Ltd has said it is set to enter the regulated markets of European Union following the receipt of Certificate of Suitability (COS) from European Directorate for the Quality of Medicines and Healthcare (EDQM) for Diosmin API. See all stories on this topic » |
Tip: Use a minus sign (-) in front of terms in your query that you want to exclude. Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment